We are live on ! Find out more

VTAK

Catheter Precision

VTAK

Market cap $286K

Delisted

VTAK was delisted on the 2nd of October, 2026.

Back to rankings

About: Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

Employees: 17

Healthcare Medical Instruments & Supplies

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Flyte Aviation Launches Under NYSE American Ticker “VJET”

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Flyte Aviation, Inc. (NYSE American: VJET) (the “Company” or “Flyte”) today revealed its new corporate identity as it launches a historic new chapter in what it believes is a disruptive technology company.

Flyte Aviation Launches Under NYSE American Ticker “VJET”

Catheter Precision to Change its Name and Ticker Symbol to Flyte Aviation and “VJET” and Effect 1-for-10 Reverse Stock Split, Monday, October 5, at Market Open

Changes highlight the Company's growth trajectory as a leading private, regional jet aviation business Changes highlight the Company's growth trajectory as a leading private, regional jet aviation business

Catheter Precision to Change its Name and Ticker Symbol to Flyte Aviation and “VJET” and Effect 1-for-10 Reverse Stock Split, Monday, October 5, at Market Open

Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil

LockeT Has Expanded to Six Hospitals in Brazil Since Its August Launch Company Engages Experienced Cardiology Group to Support Expansion Across Argentina, Chile, Colombia and Additional Latin American Markets FORT MILL, S.C., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Catheter Precision Inc. (NYSE American: VTAK), Catheter Precision, Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), a U.S.-based medical device company specializing in cardiac electrophysiology, today announced the expansion of its LockeT commercialization efforts across Latin America following the product's successful introduction in Brazil.

Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil

Flyte Partners With Christian Cowan for New York Fashion Week, Expanding Its Presence Across Global Luxury Brands

Strategic Partnership Positions Flyte at the Intersection of Private Aviation, Fashion, and Entertainment Collaboration Introduces Flyte to a High-Value Audience of Celebrities, Executives, Creators and Cultural Tastemakers

Flyte Partners With Christian Cowan for New York Fashion Week, Expanding Its Presence Across Global Luxury Brands

Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean

Landmark international milestone unlocks significant new markets and broadens Flyte's addressable aviation footprint beyond the United States New capabilities connect Flyte's growing Florida network with high-demand leisure and resort destinations throughout The Bahamas and Caribbean

Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean

Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business

Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates

New Account Creation Increased 170% During the First 17 Days of August Compared to the Same Period in July Flyte Has Added More Accounts Since July 1 Than During the Entire First Half of 2026 Growing First-Party Customer Base Now Spans 174 Airports Across 19 States FORT MILL, S.C., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced that more than 10,000 consumer accounts are now registered on the Flyte WebApp, marking a significant milestone as new account creation continues to accelerate across the Company's technology-enabled private aviation platform.

Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates

Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market

Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations

Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market

Flyte Achieves Record Revenues in July

July 2026 Revenue Increased 102% sequential July Over June to Approximately $640,000 Retail Platform, Strategic Partnerships and Influencer Marketing Fuel Accelerating Growth FORT MILL, S.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK”), today announced record monthly revenue for July 2026, marking the strongest operating month in Flyte's history as demand continues to accelerate across its private aviation platform.

Flyte Achieves Record Revenues in July

Flyte Partners with Volato AI to Become First Enterprise Customer, Accelerating Technology Strategy to Scale Regional Private Aviation

Enterprise Artificial Intelligence Deployment Expected to Enhance Customer Experience, Improve Operating Efficiency, and Increase Workforce Productivity Across Flight Operations Technology Strengthens Flyte's Scalable Regional Air Mobility Platform Through Intelligent Automation, Operational Excellence, and Long-Term Growth Initiatives FORT MILL, S.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), through its wholly owned subsidiary Flyte, today announced that Flyte has become the inaugural enterprise customer of Volato AI (NYSE American: SOAR), a purpose-built enterprise artificial intelligence platform designed specifically for business aviation.

Flyte Partners with Volato AI to Become First Enterprise Customer, Accelerating Technology Strategy to Scale Regional Private Aviation

See News Rankings

Price charts implemented using Lightweight Charts™